Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $44.77 in the prior trading day, Hims & Hers Health Inc (NYSE: HIMS) closed at $43.58, down -2.66%. In other words, the price has decreased by -$2.66 from its previous closing price. On the day, 7.3 million shares were traded. HIMS stock price reached its highest trading level at $45.14 during the session, while it also had its lowest trading level at $42.7101.
Ratios:
Our goal is to gain a better understanding of HIMS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 37.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 63.64. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on January 10, 2025, Downgraded its rating to Sell and sets its target price to $25 from $24 previously.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 17, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $42.Morgan Stanley initiated its Overweight rating on December 17, 2024, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 10 ’25 when Chi Michael sold 7,259 shares for $43.28 per share. The transaction valued at 314,170 led to the insider holds 193,601 shares of the business.
Okupe Oluyemi sold 11,581 shares of HIMS for $498,100 on Feb 10 ’25. The Chief Financial Officer now owns 107,789 shares after completing the transaction at $43.01 per share. On Feb 10 ’25, another insider, Chi Michael, who serves as the Officer of the company, bought 7,259 shares for $43.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 9521315840 and an Enterprise Value of 9278606336. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 100.81, and their Forward P/E ratio for the next fiscal year is 83.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.67 while its Price-to-Book (P/B) ratio in mrq is 21.57. Its current Enterprise Value per Revenue stands at 7.471 whereas that against EBITDA is 155.363.
Stock Price History:
The Beta on a monthly basis for HIMS is 1.39, which has changed by 3.4814816 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $46.01, while it has fallen to a 52-week low of $9.14. The 50-Day Moving Average of the stock is 39.96%, while the 200-Day Moving Average is calculated to be 97.79%.
Shares Statistics:
The stock has traded on average 15.74M shares per day over the past 3-months and 14840480 shares per day over the last 10 days, according to various share statistics. A total of 209.44M shares are outstanding, with a floating share count of 176.71M. Insiders hold about 19.12% of the company’s shares, while institutions hold 65.41% stake in the company. Shares short for HIMS as of 1738281600 were 58208349 with a Short Ratio of 3.59, compared to 1735603200 on 52121449. Therefore, it implies a Short% of Shares Outstanding of 58208349 and a Short% of Float of 30.349999999999998.
